stars 1 stars 2 stars 3

BMSEED is redefining pre-clinical research by addressing one of the most costly challenges in drug development: clinical trial failure. Our MEASSuRE platform recreates the dynamic cellular environment of the human body in vitro—integrating electrophysiology, mechanical and electrical stimulation, microfluidics, and live-cell imaging. Designed for both 2D/3D cell cultures and organoids, the system enables more physiologically relevant data from the start. At the core is our proprietary stretchable multielectrode array (sMEA), uniquely combining biomechanics and electrophysiology to capture real-time, high-fidelity signals under dynamic strain. We also offer the industry’s best-value electrophysiology acquisition system, with a wide range of MEAs—standard, stretchable, and microfluidic—to fit diverse research needs. Paired with our precision cell stretchers, researchers gain full control over strain waveforms and deformation profiles to model both healthy and pathological conditions. By enabling more predictive and representative in vitro models, BMSEED helps reduce trial costs and accelerate the development of effective therapies. 📩 Contact: info@bmseed.com 🌐 Learn more: www.bmseed.com #PreClinicalInnovation #sMEA #Electrophysiology #CellCulture #Microfluidics #DrugDiscovery #BMSEED

BMSEED Questions

The BMSEED annual revenue was $3 million in 2026.

Oliver Graudejus is the Founder of BMSEED.

4 people are employed at BMSEED.

BMSEED is based in Mesa, Arizona.

The NAICS codes for BMSEED are [5417, 54, 541713, 541, 54171].

The SIC codes for BMSEED are [873, 87].

Top BMSEED Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users